An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Vol 18 (11). Elsevier, S296-S297. ISSN: 1556-0864. EISSN: 1556-1380.

Metadata

Item Type: Conference abstract
Authors/Creators:
  • Horne, A.
  • Brown, S.
  • Coyle, V.
  • Franks, K.
  • Hassani, A.
  • Harrow, S.
  • Hatton, M.
  • Hiley, C.
  • Kendall, J.
  • Oughton, J.B. ORCID logo https://orcid.org/0000-0002-2047-804X
  • Shaw, P.
  • Walker, F.
  • Yang, H.
  • Chalmers, A.J.
  • Faivre-Finn, C.
  • Greystoke, A.
Keywords: Radiotherapy trial, Early phase study, DNA damage response inhibitors
Dates:
  • Published (online): 31 October 2023
  • Published: 31 October 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Date Deposited: 31 Jan 2024 10:09
Last Modified: 05 Mar 2026 11:57
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.jtho.2023.09.509
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)